Listed on GrantGunner. Last checked 4 Jun 2026.
About this grant
A funding opportunity for early-stage cancer researchers in Europe, focusing on tumor heterogeneity. Six to eight shortlisted applicants will be invited to submit a detailed proposal, and two top-ranked projects (one Swiss, one from another European country) will receive 500,000 Swiss francs total. Applications require a note of intent by April 30, 2026.
Who can apply
Early-stage researchers under 45 with a PhD or MD holding an independent position at a hospital, university, or research institute in Europe (e.g. junior group leaders, assistant professors, lecturers, scientists establishing their own research group).